Literature DB >> 2379623

Evidence of luteinizing hormone secretion in hypothalamic amenorrhea associated with weight loss.

A D Genazzani1, F Petraglia, G Fabbri, A Monzani, V Montanini, A R Genazzani.   

Abstract

The lack of plasma luteinizing hormone (LH) pulsatile pattern or episodic LH secretory bursts during night have been demonstrated in hypothalamic amenorrhea. The availability of both sensitive and specific immunofluorimetric assay and algorithm for pulse detection enabled us to reanalyze the question of whether or not patients with hypothalamic amenorrhea secrete LH in a pulsatile fashion. Seven women with secondary amenorrhea associated with weight loss and four normally cycling women were studied, sampling every 5 minutes for 8 hours. Control subjects were studied during four different phases of the menstrual cycle. In all amenorrheic patients, a frequent LH pulsatile secretion, with pulses of low amplitude, was found (10.7 +/- 1.4 peaks/8 h; mean +/- SEM). The pulse frequency was significantly higher (P less than 0.05) than any phases of the control group (early follicular: 7 +/- 0.4 peaks/8 h; late follicular: 6.8 +/- 0.6 peaks/8 h; early luteal: 4.3 +/- 0.4 peaks/8 h; late luteal: 7 +/- 0.3 peaks/8 h). The LH pulsatile release in amenorrheic patients showed a mean pulse duration and amplitude shorter than in any phase of the menstrual cycle of the controls. In conclusion, in weight-loss-related-amenorrhea, the major change was not the absence of the LH pulsatile release but its increased frequency with reduced pulse amplitude.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2379623     DOI: 10.1016/s0015-0282(16)53693-0

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  4 in total

Review 1.  Functional hypothalamic and drug-induced amenorrhea: an overview.

Authors:  A Lania; L Gianotti; I Gagliardi; M Bondanelli; W Vena; M R Ambrosio
Journal:  J Endocrinol Invest       Date:  2019-02-11       Impact factor: 4.256

2.  The use of a combined regimen of GnRH agonist plus a low-dose oral contraceptive improves the spontaneous pulsatile LH secretory characteristics in patients with polycycstic ovary disease after discontinuation of treatment.

Authors:  A D Genazzani; C Battaglia; O Gamba; F Petraglia; B Malavasi; A R Genazzani
Journal:  J Assist Reprod Genet       Date:  2000-05       Impact factor: 3.412

3.  Acetyl-L-carnitine (ALC) administration positively affects reproductive axis in hypogonadotropic women with functional hypothalamic amenorrhea.

Authors:  A D Genazzani; C Lanzoni; F Ricchieri; S Santagni; E Rattighieri; E Chierchia; P Monteleone; V M Jasonni
Journal:  J Endocrinol Invest       Date:  2010-04-22       Impact factor: 4.256

4.  Estrogen replacement therapy modulates spontaneous GH secretion but does not affect GH-RH-induced GH response and low T3 syndrome in women with hypothalamic amenorrhea associated to weight-loss.

Authors:  A D Genazzani; O Gamba; F Petraglia
Journal:  J Endocrinol Invest       Date:  1998-06       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.